Bio-Techne Corp’s recently made public that its Director Herr Amy E. unloaded Company’s shares for reported $0.12 million on Feb 14 ’25. In the deal valued at $65.96 per share,1,860 shares were sold. As a result of this transaction, Herr Amy E. now holds 1,976 shares worth roughly $0.13 million.
Then, JOSHUA MOLHO bought 1,860 shares, generating $122,691 in total proceeds.
Before that, Kelderman Kim sold 13,392 shares. Bio-Techne Corp shares valued at $1,035,013 were divested by the Chief Executive Officer at a price of $77.29 per share. As a result of the transaction, Kelderman Kim now holds 39,004 shares, worth roughly $2.53 million.
Robert W. Baird downgraded its Bio-Techne Corp [TECH] rating to a Neutral from a an Outperform in a research note published on February 19, 2025; the price target was decreased to $68 from $88. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in late May from “a Buy” to “a Neutral”. Scotiabank began covering TECH with “Sector outperform” recommendation on February 08, 2024. Stifel revised its rating on February 02, 2024. It rated TECH as “a Hold” which previously was an “a Buy”.
Price Performance Review of TECH
On Friday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -0.87% to $64.92. Over the last five days, the stock has lost -2.77%. Bio-Techne Corp shares have fallen nearly -9.87% since the year began. Nevertheless, the stocks have fallen -7.69% over the past one year. While a 52-week high of $85.57 was reached on 02/05/25, a 52-week low of $61.16 was recorded on 02/19/25. SMA at 50 days reached $73.13, while 200 days put it at $74.71.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 64.04, which if violated will result in even more drops to 63.17. On the upside, there is a resistance level at 66.33. A further resistance level may holdings at 67.75. The Relative Strength Index (RSI) on the 14-day chart is 29.96, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.71, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.06%. Stochastics %K at 12.01% indicates the stock is a buying.
The most recent change occurred on December 07, 2023 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.
